跳至主要内容
临床试验/NL-OMON50568
NL-OMON50568招募中不适用

A clinical investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the treatment of Non Allergic Rhinitis (KOSNAR) - Chordate System S101 Non Allergic Rhinitis Clinical Investigation

Chordate medical AB0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with persistent (>12w) symptoms of non-allergic rhinitis dominated by
  • nasal congestion (± secretion) for an average of at least 1 h per day for at
  • least 5 days during a period of 14 days.
  • 2. Having nasal congestion as major symptom, and a median nasal congestion
  • score of at least 2 (scale 0-3)
  • 3. Male or female 18 * 65 years
  • 4. Judged by the Investigator as suitable for participation in the study
  • without safety concerns based on medical history and physical examination.
  • 5. Willing and able to provide written informed consent prior to participation
  • in the clinical investigation
  • 6. Willing and able to comply with all study related procedures

排除标准

  • Patients with Allergic rhinitis, demonstrated by either positive skin prick
  • test, Phadiatop or RAST during the last year.
  • 2. Ongoing respiratory tract infection including nasal cavity at inclusion
  • 3. Systemic steroid treatment less than 4 weeks before the inclusion in the
  • 4. Patients with a history of nasal surgery like: septoplasty, cosmetic
  • surgery, conchal surgery or any other nasal surgery except closed reposition
  • for nasal fracture during last year
  • 5. History of frequent nose bleeds or a condition that increases the risk of
  • excessive bleeding
  • 6. Pronounced anterior septal deviation or other significant nasal pathology at
  • endoscopic examination
  • 7. Current malignancy of any kind
  • 8. Known allergy to polyvinylchloride or medicinal liquid paraffin
  • 9. Any disease, condition (medical or surgical) or drug or alcohol abuse which,
  • in the opinion of the investigator, might compromise the study results, or
  • would place the patient at increased risk.
  • 10. Any implant with an electrical and/or neurostimulator device, including but
  • not limited to cardiac pacemaker, defibrillator, vagal neurostimulator, deep
  • brain stimulation, spinal stimulator, bone growth stimulator, or cochlear
  • implant or any other implant in the head-, and neck region.
  • 11. Previous treated with radiation on the face, head or neck regions
  • 12. Female patients who are pregnant or become pregnant at any time from
  • inclusion of the study until end of the 8 week follow-up visit
  • 13. Received study drug in a clinical trial for an investigational drug within
  • the previous 30 days, or 5 half-lives, whichever is longer

研究者

相似试验